Compound Inventory Clause Samples

Compound Inventory. Schedule 2.2(a)(v) sets forth the Compound Inventory as of the second Business Day prior to the date hereof. As of the date hereof, the Compound Inventory is (a) free from any material defect or deficiency, (b) is in good and usable condition for its intended purpose in the ordinary course of business and (c) meets or exceeds in all material respects all of the applicable requirements and specifications.
Compound Inventory. Galectin Therapeutics will use its reasonable commercial efforts to maintain an inventory of Compound sufficient to supply Procaps needs as set forth in the then current Marketing and Distribution Plan such that Compound will be shipped to Procaps within ninety (90) days of receipt by Galectin Therapeutics of a Product Order.
Compound Inventory. Within [*] days after the Effective Date, MRKDG shall transfer and deliver to Company the Compound Inventory. In addition, MRKDG will use Commercially Reasonable Efforts to locate and, if available, will transfer to Company related materials for the Compounds as listed on Schedule 3.4(a). Delivery shall be [*]. It is understood between the Parties that the Compound Inventory in the form of drug substance will be transferred from MRKDG to Company while the Compound Inventory in the form of drug product, which is stored at MRKDG’s contract manufacturing organization, will be transferred upon Company’s request. If necessary, MRKDG will authorize its contract manufacturing organization (e.g., by letter) to transfer the Compound Inventory in the form of drug product to Company or Company’s designee.
Compound Inventory. Upon termination of this Agreement for any reason, to the extent ALZA has inventory of Compound that it will not use for manufacture under other provisions of this Agreement, if requested by Ardent in writing, ALZA will sell to Ardent such unused Compound. If such Compound was provided to ALZA by Ardent, Ardent will reimburse ALZA its costs of returning the Compound and the amounts ALZA paid to Ardent for such Compound. For all other Compound, Ardent will pay ALZA for such Compound [***]. [*Confidential treatment has been requested as to certain portions of this document. Each such portion, which has been omitted herein and replaced with a series of three asterisks [***], has been filed separately with the Securities and Exchange Commission.]
Compound Inventory. Upon expiration or earlier termination of each of the Research Term and the Research Term Tail, the Parties shall prepare and exchange